Beyond the complications: medium-term anatomical, sexual and functional outcomes following removal of trocar-guided transvaginal mesh. A retrospective cohort study

International Urogynecology Journal, 04/30/2012

There were no symptoms relating to prolapse in any of the women at 6 weeks, 6, 12 or 24 months. Authors report satisfactory outcomes following removal of a complicated TVM kit.

Methods

  • This was a retrospective analysis of a clinical database of women who had developed a complication following a TVM procedure.
  • This included dyspareunia, mesh erosion, urinary symptoms, mesh contraction and prolapse recurrence.
  • Pre– and post–operatively, we assessed the women for prolapse, stress incontinence, urgency, defecatory difficulty, digitation, pain, dyspareunia and apareunia.
  • They also recorded the Pelvic Organ Prolapse Quantification (POP–Q) score.
  • The TVM was removed and a Biodesign graft was used in the majority of cases to prevent further prolapse.
  • Follow–up was at 6 weeks, 6 months, 1 and 2 years.

Results

  • In the cohort of 21 women, 18 required surgery for pain and/or dyspareunia; 20 women had reached the 6–week follow–up at the time of analysis.
  • At 6 weeks, two women still had pain and required a second intervention.
  • Fifteen women had reached a 6–month follow–up and only one woman had persistent pain requiring repeat surgery.
  • Of the 15 women, 7 were sexually active and in 6 cases the dyspareunia had resolved completely with 1 woman retaining an element of pain at intercourse.
  • Six women had been seen at 12 months and all four of the sexually active women had no dyspareunia.
  • There were no symptoms relating to prolapse in any of the women at 6 weeks, 6, 12 or 24 months.

Print Article Summary Cat 2 CME Report